New Zealand - English - Ministry for Primary Industries

phoenix pharm distributors ltd - xylazine - xylazine 20 g/litre - sedative

New Zealand - English - Ministry for Primary Industries

phoenix pharm distributors ltd - xylazine - xylazine 50 g/litre - sedative

New Zealand - English - Ministry for Primary Industries

phoenix pharm distributors ltd - xylazine - xylazine 100 g/litre - sedative

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - xylazine hydrochloride (unii: ngc3s0882s) (xylazine - unii:2kfg9tp5v8) - xylazine 495 g in 500 g

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - xylazine hydrochloride (unii: ngc3s0882s) (xylazine - unii:2kfg9tp5v8) - xylazine 99 g in 100 g

United States - English - NLM (National Library of Medicine)

letco medical, llc - xylazine hydrochloride (unii: ngc3s0882s) (xylazine - unii:2kfg9tp5v8) -

United States - English - NLM (National Library of Medicine)

darmerica, llc - xylazine hydrochloride (unii: ngc3s0882s) (xylazine hydrochloride - unii:ngc3s0882s) -

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - xylazine hydrochloride (unii: ngc3s0882s) (xylazine hydrochloride - unii:ngc3s0882s) -

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - xylazine as the hydrochloride - parenteral liquid/solution/suspension - xylazine as the hydrochloride thiazole active 100.0 mg/ml - analgesic+musculoskeletal

United States - English - NLM (National Library of Medicine)

cronus pharma llc - xylazine hydrochloride (unii: ngc3s0882s) (xylazine - unii:2kfg9tp5v8) - indications: xylazine injection should be used in horses when it is desirable to produce a state of sedation. it has been successfully used when conducting various diagnostic, orthopedic and dental procedures of short duration. it may also be used as a preanesthetic to local or general anesthesia. contraindications:  xylazine injection should not be used in conjunction with neuroleptics or tranquilizers. not for use in humans. keep out of reach of children. avoid skin, eye or mucosal contact. use caution while handling and using filled syringes. absorption of the active ingredients is possible following exposure via the skin, eye or mucosa. in case of accidental eye exposure, flush eyes with water for 15 minutes, remove contact lenses then continue to flush. in case of accidental skin exposure, wash with soap and water and remove contaminated clothing. if symptoms occur, seek the advice of a physician. in case of accidental oral intake or self-injection, seek medical advice immediately and show the package insert to the physician. do not drive as sedation, loss of consciousness, and changes in blood pressure may occur. persons with cardiovascular disease (for example, hypertension or ischemic heart disease) should take special precautions to avoid any exposure to this product. pregnant women should exercise special caution to avoid exposure. uterine contractions and decreased fetal blood pressure may occur after accidental systemic exposure. persons with known hypersensitivity to any of the ingredients should avoid contact with xylazine injection. caution should be exercised when handling sedated animals. handling or any other sudden stimuli, including noise, may cause a defense reaction in an animal that appears to be heavily sedated.